2-69400455-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The ENST00000410022.7(NFU1):c.629G>T(p.Cys210Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000781 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000410022.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFU1 | NM_001002755.4 | c.629G>T | p.Cys210Phe | missense_variant | 7/8 | ENST00000410022.7 | NP_001002755.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFU1 | ENST00000410022.7 | c.629G>T | p.Cys210Phe | missense_variant | 7/8 | 1 | NM_001002755.4 | ENSP00000387219 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251462Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135902
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000756 AC XY: 55AN XY: 727204
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 1 Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 10, 2022 | This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 210 of the NFU1 protein (p.Cys210Phe). This variant is present in population databases (rs201634470, gnomAD 0.01%). This missense change has been observed in individual(s) with multiple mitochondrial dysfunctions syndrome (PMID: 25477904, 28803783). ClinVar contains an entry for this variant (Variation ID: 336888). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Studies have shown that this missense change alters NFU1 gene expression (PMID: 28803783). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 09, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The NFU1 c.629G>T (p.Cys210Phe) variant has been reported in one study and was found in a compound heterozygous state in one individual who also carried a second missense variant; one variant was inherited from the unaffected father and the second from the unaffected mother (Invernizzi et al. 2014). The proband had high plasma lactate, hyperintensities of the white matter, and a muscle biopsy showed reduction of complex II. Western blotting performed on extracts from the individual's fibroblasts showed no reduction in the expression of NFU1 protein but a partial reduction of the subunits of complex II. Control data are unavailable for this variant, which is reported at a frequency of 0.00010 in the European (non-Finnish) population of the Exome Aggregation Consortium. The evidence for this variant is limited. The p.Cys210Phe variant is therefore classified as a variant of unknown significance but suspicious for pathogenicity for multiple mitochondrial dysfunctions syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
SPASTIC PARAPLEGIA 93, AUTOSOMAL RECESSIVE Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 09, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 24, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25477904, 34426522, 36256512, 34449775, 36358004, 35883565, 28803783) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at